Bibliothèque

Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.

With the development of comprehensive treatment, locoregional transarterial chemotherapy has become an alternative conversion therapy, palliative therapy, and neoadjuvant therapy for many solid malign…

Thérapies de Conversion

Meng, W., Pan, L., Huang, L., Li, Q., & Sun, Y. (2024). Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.. Front Oncol, 14, 1464242. https://doi.org/10.3389/fonc.2024.1464242

01/01/2024 Lire →

Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.

Immunotherapy has demonstrated a role in the therapeutic landscape of a small subset of patients with colorectal carcinoma (CRC) that harbor a microsatellite instability (MSI-H) status due to a defici…

Thérapies de Conversion

San-Román-Gil, M., Martínez-Delfrade, I., Albarrán-Fernández, V., Guerrero-Serrano, P., Pozas-Pérez, J., Chamorro-Pérez, J., Rosero-Rodríguez, D., Sotoca-Rubio, P., Barrill-Corpa, A. M., Alia-Navarro, V., González-Merino, C., García-de-Quevedo-Suero, C., López, V., Ruz-Caracuel, I., Perna-Monroy, C., & Ferreiro-Monteagudo, R. (2024). Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.. Front Immunol, 15, 1352262. https://doi.org/10.3389/fimmu.2024.1352262

01/01/2024 Lire →

Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.

BACKGROUND: The synergistic effect of locoregional therapy in combination with systemic therapy as a conversion therapy for unresectable hepatocellular carcinoma (uHCC) is unclear. The purpose of this…

Thérapies de Conversion

Wu, X. K., Yang, L. F., Chen, Y. F., Chen, Z. W., Lu, H., Shen, X. Y., Chi, M. H., Wang, L., Zhang, H., Chen, J. F., Huang, J. Y., Zeng, Y. Y., Yan, M. L., & Zhang, Z. B. (2024). Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.. EClinicalMedicine, 67, 102367. https://doi.org/10.1016/j.eclinm.2023.102367

01/01/2024 Lire →

Conversion practices in Aotearoa New Zealand: Developing a holistic response to spiritual abuse.

Research arising from conversion practices, also known as conversion therapy and sexual orientation and gender identity change efforts, has generally been underpinned by an emancipatory discourse that…

Trauma Psychologique Religieux Abus Spirituels et Emprise Religieuse Thérapies de Conversion

Roguski, M., & Atwool, N. (2024). Conversion practices in Aotearoa New Zealand: Developing a holistic response to spiritual abuse.. PLoS One, 19(5), e0302163. https://doi.org/10.1371/journal.pone.0302163

01/01/2024 Lire →

Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report.

Intrahepatic cholangiocarcinoma (iCCA) is a highly malignant tumor of the liver and gallbladder, which is usually diagnosed at an advanced stage and the opportunity for surgery is lost. Therefore, con…

Thérapies de Conversion

Zhao, S., Zhang, X., Luo, J., Yan, H., Zhang, J., Lin, R., & Zhu, K. (2024). Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report.. Front Oncol, 14, 1476593. https://doi.org/10.3389/fonc.2024.1476593

01/01/2024 Lire →

A case report of a patient with stage IIIa hepatocellular carcinoma complicated by early gastric cancer.

We report a case of patient with Stage IIIa Hepatocellular Carcinoma Complicated by Early Gastric Cancer. Although Stage IIIa liver cancer can be treated with surgery, the overall prognosis of surgery…

Thérapies de Conversion

Song, X., Cai, R., Wang, L., Ding, F., & Ni, H. (2024). A case report of a patient with stage IIIa hepatocellular carcinoma complicated by early gastric cancer.. Front Oncol, 14, 1440171. https://doi.org/10.3389/fonc.2024.1440171

01/01/2024 Lire →

Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report.

The diagnosis and treatment of head and neck undifferentiated carcinoma (HNUC) present significant challenges. Herein, we present the case of a patient with advanced HNUC who underwent conversion surg…

Thérapies de Conversion

Li, J., Zhan, X., Shang, W., & Song, K. (2024). Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report.. Front Immunol, 15, 1484915. https://doi.org/10.3389/fimmu.2024.1484915

01/01/2024 Lire →

Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics Model.

PURPOSE: Predicting the pathological response after neoadjuvant conversion therapy for initially unresectable hepatocellular carcinoma (HCC) is essential for surgical decision-making and survival outc…

Thérapies de Conversion

Wen, H., Liang, R., Liu, X., Yu, Y., Lin, S., Song, Z., Huang, Y., Yu, X., Chen, S., Chen, L., Qian, B., Shen, J., Xiao, H., & Shen, S. (2024). Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics Model.. J Hepatocell Carcinoma, 11, 2145-2157. https://doi.org/10.2147/JHC.S487370

01/01/2024 Lire →

Review of two immunosuppressants: tacrolimus and cyclosporine.

Immunosuppressants are vital in organ transplantation including facial transplantation (FT) but are associated with persistent side effects. This review article was prepared to compare the two most us…

Thérapies de Conversion

Lee, H., Myoung, H., & Kim, S. M. (2023). Review of two immunosuppressants: tacrolimus and cyclosporine.. J Korean Assoc Oral Maxillofac Surg, 49(6), 311-323. https://doi.org/10.5125/jkaoms.2023.49.6.311

31/12/2023 Lire →

Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer.

BACKGROUND: Interest in the field of metastatic gastric cancer has grown in recent years, and the identification of oligometastatic patients plays a critical role as it consents to their inclusion in …

Thérapies de Conversion

Bencivenga, M., Ministrini, S., Morgagni, P., Mura, G., Marrelli, D., Milandri, C., Mazzei, M. A., Berselli, M., Monti, M., Graziosi, L., Reddavid, R., Rosa, F., Solaini, L., Donini, A., Fumagalli, R. o. m. a. r. i. o. . U., Roviello, F., de, M. a. n. z. o. n. i. . G., & Tiberio, G. A. M. (2023). Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer.. Cancers (Basel), 16(1). https://doi.org/10.3390/cancers16010170

29/12/2023 Lire →

PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.

Advanced gallbladder cancer (GBC) is not amenable to surgical resection. There are limited treatment options and the prognosis is dismal. The role of immune checkpoint inhibitors in conversion therapy…

Thérapies de Conversion

Zhang, S., Nie, J., Tai, S., & Zheng, T. (2023). PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.. BMJ Case Rep, 16(12). https://doi.org/10.1136/bcr-2023-255403

20/12/2023 Lire →

Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition).

Thérapies de Conversion

Meng, Q., Yang, Z., Zhu, Z., Li, J., Bi, X., Chen, X., Hao, C., Huang, Z., Li, F., Li, X., Li, G., Yang, Y., Zhang, Y., Zhao, H., Zhao, H., Zhu, X., Zhu, J., Cai, J., Liver, T. u. m. o. r. . B. r. a. n. c. h. . o. f. . t. h. e. . C. h. i. n. a. . I. n. t. e. r. n. a. t. i. o. n. a. l. . E. x. c. h. a. n. g. e. . a. n. d. . P. r. o. m. o. t. i. v. e. . A. s. s. o. c. i. a. t. i. o. n. . f. o. r. . M. e. d. i. c. a. l. . a. n. d. . H. e. a. l. t. h. c. a. r. e. . (. C. P. A. M. )., … Liver, C. a. n. c. e. r. . P. r. o. f. e. s. s. i. o. n. a. l. . C. o. m. m. i. t. t. e. e. . o. f. . C. h. i. n. e. s. e. . M. e. d. i. c. a. l. . D. o. c. t. o. r. . A. s. s. o. c. i. a. t. i. o. n. (2023). Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition).. Chin Med J (Engl), 136(24), 2909-2911. https://doi.org/10.1097/CM9.0000000000002950

20/12/2023 Lire →